SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Responds to Recent Report Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, December 23, 2016 -- Sinovac’s Audit Committee has authorized the commencement of an internal investigation into the allegations made in the report. The Aud]